|
1
|
Yang W, Cai J, Zabkiewicz C, Zhang H, Ruge
F and Jiang WG: The effects of anesthetics on recurrence and
metastasis of cancer, and clinical implications. World J Oncol.
8:63–70. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tavare AN, Perry NJ, Benzonana LL, Takata
M and Ma D: Cancer recurrence after surgery: Direct and indirect
effects of anesthetic agents. Int J Cancer. 130:1237–1250. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Le-Wendling L, Nin O and Capdevila X:
Cancer recurrence and regional anesthesia: The theories, the data,
and the future in outcomes. Pain Med. 17:756–775. 2016.PubMed/NCBI
|
|
4
|
Tazawa K, Koutsogiannaki S, Chamberlain M
and Yuki K: The effect of different anesthetics on tumor
cytotoxicity by natural killer cells. Toxicol Lett. 266:23–31.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ohlund D, Elyada E and Tuveson D:
Fibroblast heterogeneity in the cancer wound. J Exp Med.
211:1503–1523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang TX, Guan XY and Fu L: Therapeutic
targeting of the crosstalk between cancer-associated fibroblasts
and cancer stem cells. Am J Cancer Res. 9:1889–1904.
2019.PubMed/NCBI
|
|
8
|
Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M,
Cuitiño MC, Kladney RD, Varikuti S, Kaul K, Satoskar AR, Ramaswamy
B, et al: Fibroblast-derived CXCL12 promotes breast cancer
metastasis by facilitating tumor cell intravasation. Oncogene.
37:4428–4442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang A, Zhao H, Liu X, Yu M, Chen J and
Jiang WG: Comparison of different muscle-relaxant anesthetics on
growth, migration and invasion of gastric cancer cells. Anticancer
Res. 37:4371–4378. 2017.PubMed/NCBI
|
|
10
|
Jiang A, Zhao H, Cai J and Jiang WG:
Possible effect of muscle-relaxant anaesthetics on invasion,
adhesion and migration of breast cancer cells. Anticancer Res.
36:1259–1265. 2016.PubMed/NCBI
|
|
11
|
Su X, Fan Y, Yang L, Huang J, Qiao F, Fang
Y and Wang J: Dexmedetomidine expands monocytic myeloid-derived
suppressor cells and promotes tumour metastasis after lung cancer
surgery. J Transl Med. 16:3472018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun H and Sun Y: Lidocaine inhibits
proliferation and metastasis of lung cancer cell via regulation of
miR-539/EGFR axis. Artif Cells Nanomed Biotechnol. 47:2866–2874.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang L, Hu R, Cheng Y, Wu X, Xi S, Sun Y
and Jiang H: Lidocaine inhibits the proliferation of lung cancer by
regulating the expression of GOLT1A. Cell Prolif. 50:e123642017.
View Article : Google Scholar
|
|
14
|
Deng F, Ouyang M, Wang X, Yao X, Chen Y,
Tao T, Sun X, Xu L, Tang J and Zhao L: Differential role of
intravenous anesthetics in colorectal cancer progression:
Implications for clinical application. Oncotarget. 7:77087–77095.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bao F, Kang X, Xie Q and Wu J: HIF-α/PKM2
and PI3K-AKT pathways involved in the protection by dexmedetomidine
against isoflurane or bupivacaine-induced apoptosis in hippocampal
neuronal HT22 cells. Exp Ther Med. 17:63–70. 2019.PubMed/NCBI
|
|
16
|
Wang C, Datoo T, Zhao H, Wu L, Date A,
Jiang C, Sanders RD, Wang G, Bevan C and Ma D: Midazolam and
dexmedetomidine affect neuroglioma and lung carcinoma cell biology
in vitro and in vivo. Anesthesiology. 129:1000–1014. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang HW, Wang LY, Jiang L, Tian SM, Zhong
TD and Fang XM: Amide-linked local anesthetics induce apoptosis in
human non-small cell lung cancer. J Thorac Dis. 8:2748–2757. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Piegeler T, Schlapfer M, Dull RO, Schwartz
DE, Borgeat A, Minshall RD and Beck-Schimmer B: Clinically relevant
concentrations of lidocaine and ropivacaine inhibit TNFα-induced
invasion of lung adenocarcinoma cells in vitro by blocking the
activation of Akt and focal adhesion kinase. Br J Anaesth.
115:784–791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xing W, Chen DT, Pan JH, Chen YH, Yan Y,
Li Q, Xue RF, Yuan YF and Zeng WA: Lidocaine induces apoptosis and
suppresses tumor growth in human hepatocellular carcinoma cells in
vitro and in a xenograft model in vivo. Anesthesiology.
126:868–881. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Owen S, Ye L, Sanders AJ, Mason MD and
Jiang WG: Expression profile of receptor activator of nuclear-κB
(RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast
cancer. Anticancer Res. 33:199–206. 2013.PubMed/NCBI
|
|
21
|
Hooijmans CR, Geessink FJ,
Ritskes-Hoitinga M and Scheffer GJ: A systematic review of the
modifying effect of anaesthetic drugs on metastasis in animal
models for cancer. PLoS One. 11:e01561522016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Niwa H, Rowbotham DJ, Lambert DG and Buggy
DJ: Can anesthetic techniques or drugs affect cancer recurrence in
patients undergoing cancer surgery? J Anesth. 27:731–741. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim R: Anesthetic technique and cancer
recurrence in oncologic surgery: Unraveling the puzzle. Cancer
Metastasis Rev. 36:159–177. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vazquez SM, Mladovan AG, Perez C, Bruzzone
A, Baldi A and Luthy IA: Human breast cell lines exhibit functional
alpha2-adrenoceptors. Cancer Chemother Pharmacol. 58:50–61. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szpunar MJ, Burke KA, Dawes RP, Brown EB
and Madden KS: The antidepressant desipramine and α2-adrenergic
receptor activation promote breast tumor progression in association
with altered collagen structure. Cancer Prev Res (Phila).
6:1262–1272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Piegeler T, Votta-Velis EG, Liu G, Place
AT, Schwartz DE, Beck-Schimmer B, Minshall RD and Borgeat A:
Antimetastatic potential of amide-linked local anesthetics:
Inhibition of lung adenocarcinoma cell migration and inflammatory
Src signaling independent of sodium channel blockade.
Anesthesiology. 117:548–559. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lirk P, Berger R, Hollmann MW and Fiegl H:
Lidocaine time- and dose-dependently demethylates deoxyribonucleic
acid in breast cancer cell lines in vitro. Br J Anaesth.
109:200–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang F, Wang C, Cui Y, Li S, Yao Y, Ci Y,
Wang J, Hou W, Wu A and Li E: Effects of propofol on several
membrane characteristics of cervical cancer cell lines. Cell
Physiol Biochem. 40:172–182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Z, Zhang J, Hong G, Quan J, Zhang L
and Yu M: Propofol inhibits growth and invasion of pancreatic
cancer cells through regulation of the miR-21/Slug signaling
pathway. Am J Transl Res. 8:4120–4133. 2016.PubMed/NCBI
|
|
30
|
Ecimovic P, Murray D, Doran P, McDonald J,
Lambert DG and Buggy DJ: Direct effect of morphine on breast cancer
cell function in vitro: Role of the NET1 gene. Br J Anaesth.
107:916–923. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen Y, Liang M, Zhu Y and Zhou D: The
effect of propofol and sevoflurane on the perioperative immunity in
patients under laparoscopic radical resection of colorectal cancer.
Zhonghua Yi Xue Za Zhi. 95:3440–3444. 2015.(In Chinese). PubMed/NCBI
|
|
32
|
Jaura AI, Flood G, Gallagher HC and Buggy
DJ: Differential effects of serum from patients administered
distinct anaesthetic techniques on apoptosis in breast cancer cells
in vitro: A pilot study. Br J Anaesth. 113 (Suppl 1):i63–i67. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsuchiya Y, Sawada S, Yoshioka I, Ohashi
Y, Matsuo M, Harimaya Y, Tsukada K and Saiki I: Increased surgical
stress promotes tumor metastasis. Surgery. 133:547–555. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bissell MJ and Radisky D: Putting tumours
in context. Nat Rev Cancer. 1:46–54. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen X and Song E: Turning foes to
friends: Targeting cancer-associated fibroblasts. Nat Rev Drug
Discov. 18:99–115. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
LeBleu VS and Kalluri R: A peek into
cancer-associated fibroblasts: Origins, functions and translational
impact. Dis Model Mech. 11:dmm0294472018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang M, Li Y, Zhang H and Nan F: Breast
cancer stromal fibroblasts promote the generation of
CD44+CD24− cells through SDF-1/CXCR4
interaction. J Exp Clin Cancer Res. 29:802010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Todaro M, Gaggianesi M, Catalano V,
Benfante A, Iovino F, Biffoni M, Apuzzo T, Sperduti I, Volpe S,
Cocorullo G, et al: CD44v6 is a marker of constitutive and
reprogrammed cancer stem cells driving colon cancer metastasis.
Cell Stem Cell. 14:342–356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li H, Chen Y, Xu N, Yu M, Tu X, Chen Z,
Lin M, Xie B, Fu J and Han L: AMD3100 inhibits brain-specific
metastasis in lung cancer via suppressing the SDF-1/CXCR4 axis and
protecting blood-brain barrier. Am J Transl Res. 9:5259–5274.
2017.PubMed/NCBI
|
|
40
|
Noriega-Guerra H and Freitas VM:
Extracellular matrix influencing HGF/c-MET signaling pathway:
Impact on cancer progression. Int J Mol Sci. 19:33002018.
View Article : Google Scholar
|
|
41
|
Bruzzone A, Piñero CP, Rojas P, Romanato
M, Gass H, Lanari C and Lüthy IA: α(2)-Adrenoceptors enhance cell
proliferation and mammary tumor growth acting through both the
stroma and the tumor cells. Curr Cancer Drug Targets. 11:763–774.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bruzzone A, Piñero CP, Castillo LF,
Sarappa MG, Rojas P, Lanari C and Lüthy IA: Alpha2-adrenoceptor
action on cell proliferation and mammary tumour growth in mice. Br
J Pharmacol. 155:494–504. 2008. View Article : Google Scholar : PubMed/NCBI
|
